CRISPR Therapeutics AG (CRSP) EBT Margin Growth (1y) (2017 - 2026)
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) EBT Margin Growth (1y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn | 672.00 |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | 2.23 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 13,390.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 6,324.00 |
| 5 | uniQure | 3.06 Bn | 3.06 Bn | 5.49 Mn | -64,750.00 |
| 6 | Beam Therapeutics | 2.68 Bn | 2.68 Bn | - | -2.31 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 314,854.00 |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.55 Bn | 251.87 Mn | -2,558.00 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 371.00 |
| 10 | Taysha Gene Therapies | 1.99 Bn | 1.99 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.23 Mn |
| Mar 31, 2026 | 721,994.00 |
| Dec 31, 2025 | -1.86 Mn |
| Sep 30, 2025 | 222,708.00 |
| Jun 30, 2025 | 96,626.00 |
| Mar 31, 2025 | 739,561.00 |
| Dec 31, 2024 | -24,754.00 |
| Jun 30, 2024 | -2.41 Mn |
| Mar 31, 2024 | -2.29 Mn |
| Dec 31, 2023 | 202.29 Mn |
| Jun 30, 2023 | 11.36 Mn |
| Mar 31, 2023 | 1.86 Mn |
| Dec 31, 2022 | -202.18 Mn |
| Sep 30, 2022 | -17.08 Mn |
| Jun 30, 2022 | -11.38 Mn |
| Mar 31, 2022 | 220,650.00 |
| Dec 31, 2021 | 2.99 Mn |
| Sep 30, 2021 | 4.68 Mn |
| Jun 30, 2021 | 18.03 Mn |
| Mar 31, 2021 | 2.33 Mn |